CPT Codes for PMAD Screening: A Billing Reference for OBs, Pediatricians, and PCPs

Most denials for perinatal mood and anxiety disorder (PMAD) screening trace back to one of three problems: the wrong CPT code for the setting, a missing or mismatched ICD-10 screening diagnosis, or documentation that fails to record the instrument name, score, and follow-up action. The screening itself takes three minutes. The billing piece is where revenue gets lost, and it is also where pediatric and obstetric practices diverge in ways that catch new coders off guard.

This reference covers the active codes for PMAD screening in 2026: what each code captures, when to use it, how to pair it with the correct ICD-10 diagnosis, and what payers typically require in the chart note. It assumes you are already screening with a validated instrument (EPDS, PHQ-9, GAD-7, or PHQ-2) and need the billing piece to hold up under audit.

The core CPT codes at a glance

| Code | Description | Typical setting | RVU notes | |------|-------------|-----------------|-----------| | 96161 | Administration of caregiver-focused health risk assessment instrument (e.g., EPDS of a parent during a child's visit), with scoring and documentation, per standardized instrument | Pediatric well-child visit, screening the caregiver | Reported per instrument; no time threshold | | 96127 | Brief emotional/behavioral assessment (e.g., PHQ-9, GAD-7, EPDS) with scoring and documentation, per standardized instrument | Any setting, screening the patient | Up to four instruments per encounter; bundled with most E/M | | 99420 | Administration and interpretation of health risk assessment instrument | OB, family medicine, internal medicine; patient-focused HRA | Distinct from 96127 in scope; often used for broader HRAs | | G8431 | Positive screen for clinical depression, follow-up plan documented (CMS quality measure) | Medicare quality reporting only | Not billable for revenue; tracks MIPS performance | | 1100F | Patient screened for depression (HEDIS Category II code) | HEDIS quality measure reporting | Not billable; supports quality contracts |

Two ICD-10 diagnoses drive almost every screening claim in this category:

• Z13.31, Encounter for screening for depression. Primary diagnosis for adult depression screening in any setting.
• Z13.32, Encounter for screening for maternal depression. Used postpartum, including when the mother is screened during the infant's well-child visit.

The distinction between these two codes matters more in pediatrics than most coders realize. When a pediatrician screens the mother with the EPDS at the 2-month visit, the infant is the patient of record but the screening is of the caregiver, and Z13.32 is the diagnosis that links the 96161 line to a maternal indication. Some payers want Z13.32 on the infant's claim; a smaller number require it on a maternal claim instead. Verify with your top three commercial payers before the workflow goes live.

96161 vs. 99420: the setting determines the code

The single most common coding error in PMAD screening is using 99420 in a pediatric setting or 96161 in an OB setting. The codes are not interchangeable.

96161 is caregiver-focused by definition. The patient on the encounter is someone other than the person being screened, almost always an infant or child whose parent completes the EPDS or PHQ-9. The instrument has to be validated, scored, and documented. The Bright Futures and AAP guidance, which underpins most pediatric quality contracts, explicitly supports 96161 for postpartum depression screening at the 1-, 2-, 4-, and 6-month visits.

99420 is patient-focused. The person filling out the form is the person being billed for the encounter. OB practices use 99420 (or 96127, depending on payer preference and the instrument used) when screening the pregnant or postpartum patient during her own prenatal or postpartum visit. Family medicine and internal medicine clinicians use it when screening an established adult patient during an annual or problem visit.

A useful rule: if the chart belongs to the person who took the survey, you are in 99420 or 96127 territory. If the chart belongs to someone else and a caregiver took the survey on the patient's behalf, you are in 96161 territory.

96127 is the workhorse for brief instruments

CPT 96127 covers brief, validated emotional or behavioral assessments and was designed for instruments like the PHQ-9, GAD-7, EPDS, M-CHAT, and Vanderbilt. It is reportable up to four times per encounter, one unit per distinct instrument, which is useful when an OB screens with both an EPDS and a GAD-7 at the postpartum visit.

Three points trip up new coders:

The first is bundling. Some commercial payers bundle 96127 into the E/M code on the same date of service, particularly for preventive visits (99381 through 99397). Check the payer's screening policy before assuming you can stack 96127 on a preventive E/M. Many pediatric practices have found that 96161 reimburses more reliably than 96127 at well-child visits even when both are theoretically allowable.

The second is the instrument requirement. 96127 requires a standardized, validated instrument with documented scoring. A handwritten "patient denies depression" does not qualify. The EPDS, PHQ-2, PHQ-9, and GAD-7 all meet the bar; ad hoc screening questions do not.

The third is who scores it. 96127 reimburses for the administration, scoring, and documentation regardless of who actually administers it, which means MA or RN time on intake counts. The interpretation and follow-up plan, however, must be the clinician's.

ICD-10 pairing: getting the diagnosis right

CPT codes get denied when the diagnosis on the claim does not match the procedure. For screening services, the diagnosis is almost always a Z-code, not a depression diagnosis, because the patient has not yet been diagnosed.

Use Z13.31 when screening an adult patient for depression in any non-maternal context: an annual physical, a problem visit, a Medicare wellness visit. This includes screening a pregnant patient during prenatal care if the practice or payer prefers Z13.31 over Z13.32 in pregnancy (policies vary; ACOG's billing guidance accepts either, but the postpartum window leans toward Z13.32).

Use Z13.32 specifically for maternal depression screening, including the postpartum visit and any pediatric well-child visit at which the mother is screened. This is the code that signals to the payer that the screening is occurring in a perinatal context, which matters for ACA preventive-services coverage and for several state Medicaid bonus payment structures.

If the screen is positive and the clinician makes a clinical diagnosis at that same visit, add the appropriate depression or anxiety code (F32.x, F33.x, F41.x, F53.0 for postpartum) as a secondary diagnosis. The Z-code stays on the claim because the encounter started as a screening encounter.

Documentation requirements that hold up under audit

Most payers require four elements in the chart for a screening claim to survive a post-payment review:

A named instrument. "EPDS administered" is sufficient; "screened for depression" is not. Auditors want to see that a validated tool was used.

A numeric score. The score has to appear in the note, not just in a separate scanned form. "EPDS score 14" is the minimum. Many EHRs auto-populate this from the patient questionnaire module.

A follow-up plan tied to the result. For a negative screen, "rescreen at next visit" or "rescreen in 4 weeks" is adequate. For a positive screen, the note has to show what the clinician did: referral to behavioral health, initiation of medication, suicide risk assessment, follow-up appointment scheduled. CMS quality measure G8431 specifically requires the follow-up plan, and the same standard applies in most commercial audits.

A clinician signature. The MA can administer and score. The interpretation and plan have to be authenticated by the billing clinician.

For Medicare, G8431 is reported alongside the screening CPT when the screen is positive and a follow-up plan is documented. It carries no separate reimbursement; it exists for MIPS quality scoring under the Preventive Care and Screening: Screening for Depression and Follow-Up Plan measure. The HEDIS counterpart, 1100F, functions the same way in commercial quality contracts and value-based arrangements.

USPSTF, the ACA, and patient cost-sharing

The U.S. Preventive Services Task Force gives depression screening a Grade B recommendation for adults, including pregnant and postpartum patients, and a Grade B recommendation for adolescents. Under section 2713 of the Affordable Care Act, USPSTF Grade A and B services have to be covered by non-grandfathered commercial plans without patient cost-sharing when delivered by an in-network provider.

In practice, this means EPDS or PHQ-9 screening billed under 96127, 96161, or 99420 with a Z13.31 or Z13.32 primary diagnosis should not generate a patient copay or deductible obligation on most commercial plans. When patients receive bills for screening services, the denial usually reflects a coding error (wrong CPT, wrong ICD-10, screening billed as diagnostic) rather than a coverage gap. Correcting the claim, not the policy, is almost always the fix.

ACOG's billing guidance reinforces the same workflow for OB practices: screen at the initial OB visit, at least once later in pregnancy, and at the postpartum visit, billing 96127 or 99420 with Z13.31 or Z13.32 depending on timing. ACOG's 2023 guidance also explicitly supports billing for screening at the comprehensive postpartum visit even when the visit itself is included in the global obstetric package, because screening is a separately identifiable preventive service.

State Medicaid reimbursement varies widely

Medicaid coverage for PMAD screening is mandatory under EPSDT for the pediatric patient, but the rules around screening the caregiver during a child's visit are state-specific. As of 2026, 38 states reimburse 96161 for maternal depression screening at well-child visits, but the fee schedule ranges from roughly $5 to $35 per screen, and a handful of states require the screening to be billed under the mother's Medicaid ID rather than the infant's.

A few patterns worth checking against your state's policy:

States with maternal-mortality bonus structures (including Illinois, California, New Jersey, and several others) often pay above-fee-schedule rates for documented PMAD screening at specified intervals. Some require the screening to be reported with both a CPT code and a quality measure code (1100F or a state-specific equivalent) to trigger the enhanced payment.

Some state Medicaid programs accept 99420 for maternal HRA in pregnancy but not 96127, or vice versa. The crosswalk is rarely published clearly; your billing service or MCO provider rep is usually the fastest source.

Telehealth screening is reimbursed at parity in most states post-2023, but a small number still require an in-person component for the screening service to bill. Verify before building a virtual-only screening workflow.

The codes are stable. The payer policies around them are not. A quarterly review of denial patterns, especially for 96161 and 96127 lines, catches most of the drift before it becomes a meaningful revenue leak.

FAQs

Q: Can I bill 96161 and 96127 on the same day? Yes, when the codes capture distinct screenings of distinct people. The classic example is a pediatric well-child visit where the mother completes an EPDS (bill 96161 on the infant's claim) and the toddler is screened with the M-CHAT or an ASQ (bill 96127 on the infant's claim, one unit per instrument). Both codes can appear on the same encounter because 96161 is caregiver-focused and 96127 is patient-focused. Some commercial payers bundle one or the other into the preventive E/M code, so check the specific payer's screening policy. When both are billable, sequence the codes with the most reimbursable line first and use modifier 25 on the E/M if the payer requires it to indicate a separately identifiable service.

Q: Does CPT 99420 require a separate diagnosis code from the visit's primary diagnosis? 99420 needs a screening-appropriate ICD-10 diagnosis on its claim line, typically Z13.31 for adult depression screening or Z13.32 for maternal depression screening. The diagnosis does not have to be different from the visit's primary diagnosis if the visit itself is a preventive encounter, but the Z-code has to be present somewhere on the claim to support the screening service. If the visit is problem-oriented (an established patient coming in for a specific complaint) and a screening is performed in addition, list the problem diagnosis as primary and the Z-code as secondary, with the Z-code linked to the 99420 line in the line-item diagnosis pointer field.

Q: Is EPDS screening covered under USPSTF preventive services? Yes. The USPSTF gives perinatal depression screening a Grade B recommendation, which under section 2713 of the ACA requires non-grandfathered commercial plans to cover the service without patient cost-sharing when delivered in-network. EPDS, PHQ-9, and PHQ-2 are all accepted validated instruments for the recommendation. The coverage applies to screening in pregnancy and the postpartum period, and it applies whether the screen is billed under 96127, 96161, or 99420. Patient bills for screening services typically reflect a claim-level coding error rather than a true coverage gap. Reviewing the rejected claim for the correct CPT-to-ICD pairing usually resolves the issue.

Q: How do I document a positive screen to satisfy both billing and quality measures? The note needs four elements: instrument name (e.g., "EPDS"), numeric score (e.g., "15"), clinical interpretation ("positive screen for postpartum depression"), and a specific follow-up plan ("referred to perinatal psychiatry, suicide risk assessed and negative, follow-up appointment scheduled in 1 week, safety plan documented"). For Medicare patients, append G8431 to the claim to capture the MIPS depression screening and follow-up measure. For HEDIS-reporting commercial contracts, append 1100F. Neither code carries separate reimbursement, but both are required for the quality measure to count. Suicide risk assessment is the most commonly missing piece in audits of positive-screen documentation.

Q: What is the difference between Z13.31 and Z13.32, and when does it matter? Z13.31 is the general adult depression screening code; Z13.32 is specific to maternal depression screening, including postpartum. The functional difference shows up in two places. First, some state Medicaid programs only trigger maternal mental health bonus payments or quality measure credit when Z13.32 is used. Second, several commercial payers route claims with Z13.32 through a separate preventive-services rail that bypasses copay logic, while Z13.31 occasionally drops into a behavioral health benefit category that applies cost-sharing. When screening a postpartum patient (whether at her own visit or during her infant's well-child visit), use Z13.32. For non-maternal adult screening, use Z13.31.